Search Results - "Bakker, S. J. L"

The fibrosis marker galectin-3 and outcome in the general population by de Boer, R. A., van Veldhuisen, D. J., Gansevoort, R. T., Muller Kobold, A. C., van Gilst, W. H., Hillege, H. L., Bakker, S. J. L., van der Harst, P.

“…  de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Hillege HL, Bakker SJL, van der Harst P (University of Groningen). The…”
Get full text

A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus by Roscioni, S. S., de Zeeuw, D., Hellemons, M. E., Mischak, H., Zürbig, P., Bakker, S. J. L., Gansevoort, R. T., Reinhard, H., Persson, F., Lajer, M., Rossing, P., Heerspink, H. J. Lambers

“…Aims/hypothesis Microalbuminuria is considered the first clinical sign of kidney dysfunction and is associated with a poor renal and cardiovascular prognosis…”
Get full text

Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study by Abbasi, A., Corpeleijn, E., Meijer, E., Postmus, D., Gansevoort, R. T., Gans, R. O. B., Struck, J., Hillege, H. L., Stolk, R. P., Navis, G., Bakker, S. J. L.

“…Aims/hypothesis Vasopressin plays a role in osmoregulation, glucose homeostasis and inflammation. Therefore, plasma copeptin, the stable C-terminal portion of…”
Get full text

Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33) by Boertien, W. E., Riphagen, I. J., Drion, I., Alkhalaf, A., Bakker, S. J. L., Groenier, K. H., Struck, J., de Jong, P. E., Bilo, H. J. G., Kleefstra, N., Gansevoort, R. T.

“…Aim/hypothesis Arginine vasopressin (AVP), the hormone important for maintaining fluid balance, has been shown to cause kidney damage in rodent models of…”
Get full text

Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes – contraindications and opportunities by Gant, C. M, Oosterwijk, M. M, Binnenmars, S. H, Navis, G. J, Haverkate, H, Bakker, S. J. L, Laverman, G. D

“…Abstract Objective Pharmacological inhibition of the renin-angiotensin-aldosterone-system (RAASi) is the cornerstone of hypertension treatment, renoprotection…”
Get full text

Intake of total protein, plant protein and animal protein in relation to blood pressure: a meta-analysis of observational and intervention studies by Tielemans, S M A J, Altorf-van der Kuil, W, Engberink, M F, Brink, E J, van Baak, M A, Bakker, S J L, Geleijnse, J M

“…There is growing evidence from epidemiological studies that dietary protein may beneficially influence blood pressure (BP), but findings are inconclusive. We…”
Get full text

Caloric restriction reduces proteinuria in male rats with established nephropathy by Sijbesma, J W A, van Waarde, A, Klooster, A, Kion, I, Slart, R H J A, Lammertsma, A A, Giacobbo, B Lima, Boersma, H H, Dierckx, R A J O, van Goor, H, Bakker, S J L

“…Reducing proteinuria is a crucial approach in preventing kidney function loss. Previous preclinical studies indicated that caloric restriction (CR) imposed at…”
Get full text

Hepatic Syndecan‐1 Changes Associate With Dyslipidemia After Renal Transplantation by Adepu, S., Katta, K., Tietge, U. J. F., Kwakernaak, A. J., Dam, W., van Goor, H., Dullaart, R. P. F., Navis, G. J., Bakker, S. J. L., van den Born, J.

“…Syndecan‐1 is a transmembrane heparan sulfate (HS) proteoglycan present on hepatocytes and involved in uptake of triglyceride‐rich lipoproteins via its HS…”
Get full text

Plasma procalcitonin and risk of type 2 diabetes in the general population by Abbasi, A., Corpeleijn, E., Postmus, D., Gansevoort, R. T., de Jong, P. E., Gans, R. O. B., Struck, J., Hillege, H. L., Stolk, R. P., Navis, G., Bakker, S. J. L.

Get full text

polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus by Alkhalaf, A, Bakker, S. J. L, Bilo, H. J. G, Gans, R. O. B, Navis, G. J, Postmus, D, Forsblom, C, Groop, P. H, Vionnet, N, Hadjadj, S, Marre, M, Parving, H. H, Rossing, P, Tarnow, L

“…Aims/hypothesis Homozygosity for a five leucine repeat (5L-5L) in the carnosinase gene (CNDP1) has been found to be cross-sectionally associated with a low…”
Get full text

Maternal and paternal transmission of type 2 diabetes: influence of diet, lifestyle and adiposity by Abbasi, A., Corpeleijn, E., van der Schouw, Y. T., Stolk, R. P., Spijkerman, A. M. W., van der A, D. L., Navis, G., Bakker, S. J. L., Beulens, J. W. J.

“…  Abbasi A, Corpeleijn E, van der Schouw YT, Stolk RP, Spijkerman AMW, van der A DL, Navis G, Bakker SJL, Beulens JWJ (University Medical Center Groningen,…”
Get full text

Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus by Pena, M. J., Lambers Heerspink, H. J., Hellemons, M. E., Friedrich, T., Dallmann, G., Lajer, M., Bakker, S. J. L., Gansevoort, R. T., Rossing, P., de Zeeuw, D., Roscioni, S. S.

“…Aims Early detection of individuals with Type 2 diabetes mellitus or hypertension at risk for micro‐ or macroalbuminuria may facilitate prevention and…”
Get full text

Telomere length loss due to smoking and metabolic traits by Huzen, J., Wong, L. S. M., Veldhuisen, D. J., Samani, N. J., Zwinderman, A. H., Codd, V., Cawthon, R. M., Benus, G. F. J. D., Horst, I. C.C., Navis, G., Bakker, S. J. L., Gansevoort, R. T., Jong, P. E., Hillege, H. L., Gilst, W. H., Boer, R. A., Harst, P.

“…Objectives Human age‐dependent telomere attrition and telomere shortening are associated with several age‐associated diseases and poorer overall survival. The…”
Get full text

Periodontitis is characterized by elevated PAI-1 activity by Bizzarro, S., Van Der Velden, U., Ten Heggeler, J. M. A. G., Leivadaros, E., Hoek, F. J., Gerdes, V. E. A., Bakker, S. J. L., Gans, R. O. B., Ten Cate, H., Loos, B. G.

“…Objectives: Periodontitis is a chronic infectious disease and has been associated with cardiovascular diseases (CVD). We investigated whether plasma levels of…”
Get full text

Effects of sodium and potassium supplementation on blood pressure and arterial stiffness: a fully controlled dietary intervention study by Gijsbers, L, Dower, J I, Mensink, M, Siebelink, E, Bakker, S J L, Geleijnse, J M

“…We performed a randomised, placebo-controlled, crossover study to examine the effects of sodium and potassium supplementation on blood pressure (BP) and…”
Get full text

Chronic pain after hand‐assisted laparoscopic donor nephrectomy by Zorgdrager, M., van Londen, M., Westenberg, L. B., Nieuwenhuijs‐Moeke, G. J., Lange, J. F. M., de Borst, M. H., Bakker, S. J. L., Leuvenink, H. G. D., Pol, R. A.

“…Background Data on chronic pain after kidney donation are sparse. The aim of this study was to assess the incidence of chronic pain after hand‐assisted…”
Get full text

Early development of the metabolic syndrome after chemotherapy for testicular cancer by de Haas, E.C., Altena, R., Boezen, H.M., Zwart, N., Smit, A.J., Bakker, S.J.L., van Roon, A.M., Postma, A., Wolffenbuttel, B.H.R., Hoekstra, H.J., van Leeuwen, F.E., Sleijfer, D.T., Gietema, J.A.

“…The metabolic syndrome (MS) might increase the risk of cardiovascular disease in testicular cancer (TC) survivors. We investigated its prevalence, development,…”
Get full text

Optimal dosing of renin-angiotensin-aldosterone system blockers for renal protection: a solved issue? by Laverman, G. D, Bakker, S. J. L, Navis, G. J

Get full text

Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review by Hellemons, M. E., Kerschbaum, J., Bakker, S. J. L., Neuwirt, H., Mayer, B., Mayer, G., de Zeeuw, D., Lambers Heerspink, H. J., Rudnicki, M.

“…Diabet. Med. 29, 567–577 (2012) Novel biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes have been recently identified…”
Get full text

Emerging Role of Gasotransmitters in Renal Transplantation by Snijder, P. M., van den Berg, E., Whiteman, M., Bakker, S. J. L., Leuvenink, H. G. D., van Goor, H.

“…Once patients with kidney disease progress to end‐stage renal failure, transplantation is the preferred option of treatment resulting in improved quality of…”
Get full text